Veterinary Medicines

ZORABEL 50 mg/mL ORAL SUSPENSION FOR PIGS.

Authorised
  • Toltrazuril
Download as PDF

Product identification

Medicine name:
ZORABEL 50 mg/mL ORAL SUSPENSION FOR PIGS.
Zorabel 50 mg/ml oral suspension
Active substance:
  • Toltrazuril
Target species:
  • Pig (piglet)
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Toltrazuril
    50.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Oral suspension
Withdrawal period by route of administration:
  • Oral use
    • Pig (piglet)
      • Meat and offal
        73
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP51AJ01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Denmark
Available in:
  • Denmark
Package description:
  • bottle of 1 L
  • box containing 15 bottles of 250 ml
  • box containing 1 bottle of 250 ml
  • box containing 1 bottle of 100 ml

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Hybrid application (Article 13(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Vetpharma Animal Health S.L.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Mevet S.A.U.
Responsible authority:
  • Danish Medicines Agency
Authorisation number:
  • 51618
Date of authorisation status change:
Reference member state:
  • Spain
Procedure number:
  • ES/V/0194/001
Concerned member states:
  • Czechia
  • Denmark
  • France
  • Hungary
  • Ireland
  • Poland
  • Portugal
  • Slovakia
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 11/04/2023
Download
Danish (PDF)
Published on: 13/11/2023
Download

Package Leaflet

English (PDF)
Published on: 11/04/2023
Download

Labelling

English (PDF)
Published on: 11/04/2023
Download

eu-PUAR-zorabel--50-mg-ml-oral-suspension-for-pigs.-en.pdf

English (PDF)
Published on: 11/04/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."